In today’s complex healthcare landscape, Medical Science Liaisons (MSLs) are under pressure to deliver more than trusted relationships. They must provide personalized, data-driven engagement that creates measurable value.
While 58% of healthcare professionals rank MSL interactions as more valuable than those with sales representatives, trust alone is no longer enough. With limited time, evolving therapeutic complexity and rising expectations, MSLs need new tools and strategies to ensure their work drives scientific impact and aligns with brand objectives.
Susan Giacalone, Vice President of Medical Deployment at EVERSANA, outlines how augmented intelligence, structured insight generation and custom performance metrics are reshaping MSL engagement:
-
AI-enabled engagement supports personalized, efficient, and measurable scientific exchange.
-
Insight transformation ensures raw data becomes actionable guidance aligned with strategy.
-
Custom metrics such as Scientific Share of Voice, KOL engagement rates and congress activity tracking prove impact and ROI.
EVERSANA’s approach shows how modernized MSL teams can accelerate clinical outcomes, reduce development costs and strengthen HCP partnerships.
Download the full article to see how personalized, measurable engagement is defining the future of Medical Affairs.
Author
Susan leads field medical efforts for EVERSANA. As a leader in the life sciences industry, she brings more than 20 years of medical affairs experience across multiple therapeutic areas, including oncology, hepatology and rare…